Technohal

prof.dr. S. Siesling (Sabine)

Hoogleraar
BMS-TPS-HTSR
Technohal 3105
s.siesling@utwente.nl
+31534895638
Visitekaartje

Expertises

  • Medicine and Dentistry

    • Breast Cancer
    • Patient
    • Therapeutic Procedure
    • Cancer Registry
    • Survival
    • Neoplasm
    • Recurrent Disease
    • Malignant Neoplasm

Organisaties

Publicaties

Jump to: 2026 | 2025

2026

Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study (2026)The Lancet Regional Health - Europe, 62. Article 101574. Cardoso, R., Ola, I., Jansen, L., Hackl, M., Ihle, P., Francart, J., Van Damme, N., Valerianova, Z., Atanasov, T., Májek, O., Ngo, O., Innos, K., Mägi, M., Yonli, S. D., Woronoff, A. S., Tretarre, B., Poncet, F., Katalinic, A., Walsh, P. M., … Brenner, H.https://doi.org/10.1016/j.lanepe.2025.101574Less endocrine therapy in HR+/HER2- breast cancer: a nationwide trend despite unchanged guidelines (2026)The Breast, 85. Article 104664. Verreck, E. E. F., Postma, E. L., Oostergo, T., Meijer, J., Eijkelboom, A., Siesling, S., Rizopoulos, D., van Dalen, T. & Volders, J. H.https://doi.org/10.1016/j.breast.2025.104664Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: A population-based study including 121347 patients (2026)The Breast, 85. Article 104673. Meijer, J., van den Bongard, H. J. G. D., Koppert, L. B., Menke-van der Houven van Oordt, C. W., de Munck, L., van Nijnatten, T. J. A., van der Sangen, M. J. C., Schipper, R. J., Schmidt, M. K., Smidt, M. L., Vreuls, W., van Maaren, M. C. & Siesling, S.https://doi.org/10.1016/j.breast.2025.104673Acute toxicity and quality of life after 5-fraction versus 15-fraction adjuvant radiotherapy following conventional or oncoplastic breast-conserving surgery − a real-world prospective cohort study (2026)Radiotherapy and oncology, 214. Article 111310. Mink van der Molen, D. R., Batenburg, M. C. T., van ’t Westeinde, T., Houweling, A. C., Maarse, W., Verhoeven, K., Strijbos, J., Murrer, L., Siesling, S., Monninkhof, E. M., Verkooijen, H. M., Boersma, L. J. & van der Leij, F.https://doi.org/10.1016/j.radonc.2025.111310

2025

Comparative validation of PREDICT versions 3.1 and 2.2 for overall survival in the Dutch breast cancer population (2025)The Breast, 85. Article 104681 (E-pub ahead of print/First online). Vreven, L. W. A., Verheul, E. M., van Maaren, M. C., Doornkamp, F., Schipper, R.-J., Siesling, S., Pharoah, P. D. P., Tjan-Heijnen, V. C. G. & Voogd, A. C.https://doi.org/10.1016/j.breast.2025.104681Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020–2023, using registry data and questionnaires (2025)Radiation Oncology, 20(1). Article 99. Eijkelboom, A. H., van Beek, E. J. A., Stam, M. R., Westhoff, P., van Maaren, M. C., Sattler, M. G. A., Bantema-Joppe, E. J., Verheij, M., van den Bongard, D. H. J. G. & Siesling, S.https://doi.org/10.1186/s13014-025-02669-wPathological complete response and survival after neoadjuvant chemotherapy in patients with stage I TNBC: a registry-based study (2025)ESMO Open, 10(12). Article 105923. de Graaf, M., Gielen, R. C. A. M., Balduzzi, S., Siesling, S., Linn, S. C. & Kok, M.https://doi.org/10.1016/j.esmoop.2025.105923The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study (2025)Breast cancer research, 27(1). Article 129. Jong, C. L. d., Siesling, S., Puts, G. C. W. M., Jager, A. & Ausems, M. G. E. M.https://doi.org/10.1186/s13058-025-02081-yFrom Promise to Practice: Evaluating the Health and Economic Impact of AI in Breast Cancer Imaging Surveillance (2025)[Thesis › PhD Thesis - Research UT, graduation UT]. University of Twente. Voets, M.https://doi.org/10.3990/1.9789036568982Disparities in cancer incidence and stage at diagnosis between male and female patients in the Netherlands (2025)European journal of cancer, 230, 116063. Article 116063. Hoveling, L. A., Eijkelboom, A., Schuurman, M., Bode, C., Atema, V., van Laarhoven, H. W. M., Oertelt-Prigione, S., Richters, A., van Asselt, K. M., Siesling, S. & Aarts, M. J.https://doi.org/10.1016/j.ejca.2025.116063Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39 countries and territories (2025)The Lancet, 406(10517), 2325-2348. Allemani, C., Minicozzi, P., Morawski, B., Lima, C. A., Bennett, D., Pongnikorn, D., Petrova, D., Innos, K., Girardi, F., Galán Alvarez, Y., Schaffar, R., Dal Maso, L., Molinié, F., Valkov, M., Phillips, K., Siesling, S., Schultz, A., Daubisse-Marliac, L., Marcos-Gragera, R. & Di Carlo, V.https://doi.org/10.1016/S0140-6736(25)01383-2Systematic review and meta-analysis on the effect of physical exercise on self-reported pain in patients with metastatic cancer (2025)Journal of cancer survivorship (E-pub ahead of print/First online). Sprengers, R., Monninkhof, E. M., Eijkelkamp, N., van der Wall, E., Siesling, S., May, A. M. & Hiensch, A. E.https://doi.org/10.1007/s11764-025-01936-9364TiP Early detection of symptoms during chemo(immune)therapy treatment of metastatic breast cancer using ePRO and Fitbits: The SYMPHA trial (2025)ESMO Real World Data and Digital Oncology, 10, 100560. Woudstra, L., Van den Hurk, C., Van den Berg, S., Folkert, L., Haeri, M. A., Van Hoeve, J., Drossaert, C., Van den Berg, S. M., Páez, C. G., Tol, J., Hendriks, M. P., Raijmakers, N., Jager, A. & Siesling, S.https://doi.org/10.1016/j.esmorw.2025.100560Patient perceptions around the use of clinico-pathologic and genomic tools in the management of early breast cancer (2025)Breast cancer research and treatment, 214(1), 87-99. Beltran-Bless, A. A., Saunders, D., Clemons, L., Machado, I., Pond, G., Hutton, B., El-Emam, K., McGee, S., Ng, T. L., Savard, M. F., Hilton, J., Rushton, M., Larocque, G., Siesling, S., Leblanc, A., Vandermeer, L. & Clemons, M.https://doi.org/10.1007/s10549-025-07797-1Trends in Surgical Treatment for cT4 Breast Cancer After Neoadjuvant Systemic Therapy: A Nationwide Study in The Netherlands (2025)Annals of surgical oncology, 32(12), 8668-8677. Jansen, B. A. M., Kelder, J. C., Borchert, T., van Uden, D. J. P., van der Leij, F., Schröder, C., Doeksen, A., Siesling, S., van Maaren, M. C. & Postma, E. L.https://doi.org/10.1245/s10434-025-17585-2Trends in use of magnetic resonance imaging and partial breast irradiation between 2011–2022 in the Netherlands: A population-based study (2025)Clinical and Translational Radiation Oncology, 55. Article 101039. Civil, Y. A., Eijkelboom, A. H., Veldink, A. E., van Maarenc, M. C., Maduro, J. H., Duvivier, K. M., Siesling, S. & van den Bongard, H. J. G. D.https://doi.org/10.1016/j.ctro.2025.101039Understanding delays in breast cancer diagnosis in Africa: Key insights and contributing factors (2025)International journal of cancer, 157(9), 1830-1840. Hoveling, L. A., Heuken, L. P., Harfst, T., Schuurman, M. S., van Asselt, K. M., Siesling, S. & Bode, C.https://doi.org/10.1002/ijc.70008Breast cancer-related fatigue risk and intervention recommendations: What can and cannot be personalised? (2025)[Thesis › PhD Thesis - Research UT, graduation UT]. University of Twente. Beenhakker, L.https://doi.org/10.3990/1.9789036568425A Goal Without a Plan Is Just a Wish: Creating a Personalized Aftercare Plan for Breast Cancer Patients Supported by the Breast Cancer Aftercare Decision Aid (2025)Current Oncology, 32(10). Article 552. Dekker-Klaassen, A., Drossaert, C. H. C., Thé, R., Zeillemaker, A. M., van Hezewijk, M., De Keulenaar-Suiker, I. M., Knottnerus, B. J., Honkoop, A., van der Lee, M. L., Korevaar, J. C., Siesling, S. & van Maaren, M. C.https://doi.org/10.3390/curroncol32100552Overall survival of patients with de Novo HER2-positive metastatic breast cancer in the Netherlands from 2008 to 2017: A population-based cohort study of systemically treated patients (2025)European journal of cancer, 222. Article 115475. Ding, N., Hermans, K. E. P. E., van Nijnatten, T. J. A., Engelen, S. M. E., Tol, J., Kooreman, L., Vrancken-Peeters, M.-J. T. F. D., Siesling, S., Voogd, A. C., Tjan-Heijnen, V. C. G. & Geurts, S. M. E.https://doi.org/10.1016/j.ejca.2025.115475

Onderzoeksprofielen

Scan de QR-code of
Download vCard